The Lancet's COVID-19 Resource Centre: a report on part of The Randomised Evaluation of COVid-19 thERapY (RECOVERY) trial, and more

New COVID-19 Content is Now Available

 

Dear Victor Norberto, Editor's Pick: The drug combination lopinavir-ritonavir has been suggested as an antiviral treatment for COVID-19. An Article published in The Lancet reports on part of The Randomised Evaluation of COVid-19 thERapY (RECOVERY) trial which randomly allocated 1616 patients to receive the usual standard of care plus lopinavir-ritonavir, and 3424 patients to receive the usual standard of care alone. It concludes for in-patients hospitalised with COVID-19, lopinavir-ritonavir was not associated with reductions in 28-day mortality, duration of hospital stay, or risk of progressing to invasive mechanical ventilation or death. The authors recommend that clinical guidelines be updated based on findings from the RECOVERY trial. Read the Article here. We hope you find the Resource Centre on COVID-19 to be informative.  We want to make sure that you receive information that is interesting and relevant to you, so if you prefer to receive updates to include new Chinese translations please click here. Yours sincerely, The Lancet

NEW content on COVID-19

The Lancet Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Open Access Antiviral monotherapy for hospitalised patients with COVID-19 is not enough Open Access Power of and power over COVID-19 response guidelines Why misinterpretation of electron micrographs in SARS-CoV-2-infected tissue goes viral The Lancet Infectious Diseases Change in obstetric attendance and activities during the COVID-19 pandemic MIS-C: post-infectious syndrome or persistent infection? COVID-19: the deadly threat of misinformation The Lancet Neurology Neuropathology of patients with COVID-19 in Germany: a post-mortem case series Catch me if you can: SARS-CoV-2 detection in brains of deceased patients with COVID-19 The Lancet Psychiatry Prevalence, management, and outcomes of SARS-CoV-2 infections in older people and those with dementia in mental health wards in London, UK: a retrospective observational study The Lancet Rheumatology Viral arthritis and COVID-19 EClinicalMedicine Understanding the long-term health effects of COVID-19 Open Access Sarilumab use in severe SARS-CoV-2 pneumonia Open Access Gender differences in outcomes of cancer patients with COVID: Signal or noise? Open Access Host tolerance contributes to persistent viral shedding in COVID-19 Open Access Impact of COVID-19 pandemic on clinical and surgical breast cancer management Open Access Delirium: A suggestive sign of COVID-19 in dementia Open Access